Globus Medical, Inc. (gmed)
GMED Estimates
Public analyst price targets and consensus snapshot for Globus Medical, Inc.. Deeper estimate history and models are available in Vest Terminal.
| Last price | $73.96 |
| Analyst mean target | $103.23 |
| Analyst high target | $125.00 |
| Analyst low target | $84.00 |
| Upside vs mean target | 39.6% |
| Consensus recommendation | Buy |
| Number of analysts | 13 |
| Forward P/E | 13.70 |
Start Free — open GMED in Vest Terminal
Access live data, filings, ownership, and analysis for Globus Medical, Inc..
Globus Medical, Inc. FAQ
What does Globus Medical, Inc. (GMED) do?
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating sy…
What is GMED's P/E ratio?
Globus Medical, Inc. has a trailing P/E of 19.21× based on publicly available market data.
Does GMED pay a dividend?
Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.
What sector is GMED in?
Globus Medical, Inc. is classified in Healthcare (Medical Devices) on NYQ.
What is GMED's market capitalization?
Approximate market cap: $9.93B.
What are the main risks for GMED?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of GMED?
Potential positives include revenue growth of 5.9% year-over-year, gross margin of 69.0% supports competitive unit economics.
Where can I get analyst estimates for GMED?
Public analyst price targets and consensus for Globus Medical, Inc. are on the free /stocks/gmed/estimates page. Deeper estimate history and models are available in Vest Terminal.